Alzheimer's disease & dementia

Novel PET imaging agent detects earliest signs of Alzheimer's disease

A new highly selective PET imaging agent can detect the presence of overexpressed monoamine oxidase-B (MAO-B) in cognitively unimpaired individuals with high beta amyloid (Ab)—one of the earliest signs of Alzheimer's disease—according ...

Diseases, Conditions, Syndromes

Study explores COVID-19 effects on cognition

A new long-term study led by neuroscientists at Western University shows short-term symptoms from COVID-19, like labored breathing, fever, and dry cough, may just be the proverbial tip of the iceberg.

Neuroscience

Absence of biomarker profiles typical of Alzheimer's disease

A new study from Karolinska Institutet and the Karolinska University Hospital indicates that only a rather small proportion of individuals attending a specialized memory clinic have an Alzheimer's disease-type biomarker profile ...

Medications

Alzheimer's drug trial shows 'evidence of sustained improvement'

Almost four decades ago the University of Aberdeen's Chair in Mental Health (Clinical), Professor Claude Wischik, made a breakthrough in discovering that the neurofibrillary "tangles" associated with Alzheimer's disease were ...

page 39 from 40